๐Ÿ“Š This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cyclo Therapeutics

1.1 - Company Overview

Cyclo Therapeutics Logo

Cyclo Therapeutics

Headquarter: United States
Founded: 20XX๐Ÿ”’
Employees: 100-500๐Ÿ”’
๐ŸŒ Website

Company description

  • Provider of cyclodextrin-based therapeutics, including Trappsolยฎ Cycloโ„ข, a proprietary hydroxypropyl beta cyclodextrin formulation in clinical trials for Niemann-Pick Disease Type C1 and in a Phase 2b trial for early Alzheimerโ€™s disease, leveraging data from an Expanded Access program.

Products and services

  • Cyclodextrin-Based Drug Development: Clinical-stage efforts that develop therapeutics using cyclodextrins in drug development, focusing exclusively on cyclodextrin-enabled medicines
  • Trappsolยฎ Cycloโ„ข for Alzheimerโ€™s Disease: Investigational formulation undergoing a Phase 2b clinical trial to treat early Alzheimerโ€™s disease, leveraging data from an Expanded Access program
  • Trappsolยฎ Cycloโ„ข for Niemann-Pick Disease Type C1: Proprietary hydroxypropyl beta cyclodextrin formulation in clinical trials targeting Niemann-Pick Disease Type C1, a rare genetic disorder

Key contacts

๐Ÿ”’
๐Ÿ”’

Financial details

๐Ÿ”’

1.2 - Competitors and similar companies to Cyclo Therapeutics

Questcor Pharmaceuticals Logo

Questcor Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical treatments for serious, difficult-to-treat autoimmune and inflammatory disorders, focused on neurology and nephrology, and supporting research efforts in a variety of conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Questcor Pharmaceuticals company profile โ†’
Exzell Pharma Logo

Exzell Pharma

HQ: Canada Website
  • Description: Provider of medicines, healthcare and biopharma-based products, including EsopH OTC therapy for GERD that relieves heartburn and can be used with PPI prescriptions; Swiss Natural vitamins, supplements and minerals from natural sources; Salinex nasal spray to hydrate and cleanse; PediaVit vitamins and iron for infants and children; Koena multi-strain probiotics; and Ozonol ointment for scrapes, minor burns, and skin irritations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Exzell Pharma company profile โ†’
LEAF Pharmaceuticals Logo

LEAF Pharmaceuticals

HQ: United States Website
  • Description: Provider of biotechnology and healthcare products, including investigational anticancer drugs targeting solid tumors (LEAF-1401, LEAF-1701) with preclinical results showing reduced metastatic tumor burden in lung cancer models, superior performance in colorectal models, and minimal myelosuppression and gastrointestinal toxicity, plus LEAF-1404, a complex generic anticancer medicine manufactured under global cGMP.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full LEAF Pharmaceuticals company profile โ†’
CTI Science Logo

CTI Science

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on improving human and animal health, developing a flagship product for submission for regulatory drug approval. Founded in 2007 by Dr. Boyd E. Haley, based in Lexington, Kentucky, United States.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full CTI Science company profile โ†’
Ascendis Pharma Logo

Ascendis Pharma

HQ: United States Website
  • Description: Provider of the TransCon prodrug technology platform, which transiently conjugates an inert carrier to a parent drug for systemic or localized release, and a pipeline of investigational therapies: TransCon hGH for growth hormone deficiency, TransCon PTH for hypoparathyroidism, TransCon CNP for achondroplasia, and oncology candidates TransCon TLR7/8 Agonist and TransCon IL-2 ฮฒ/ฮณ.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: โ—โ—โ—โ—โ—
  • Total funding raised: $โ—โ—โ—m
  • Backers: โ—โ—โ—โ—โ—โ—โ—โ—โ—โ—
  • Acquisitions: โ—โ—
View full Ascendis Pharma company profile โ†’
๐Ÿ”’

2.M&A buyers

2.1 Potential strategic acquirers in the sector

๐Ÿ”’
๐Ÿ”’
๐Ÿ”’
๐Ÿ”’ View all strategic buyers with complete profiles
Start Free Trial โ†’

2.2 - Strategic buyer groups for Cyclo Therapeutics

๐Ÿ”’

Buyer group 1: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”’

Buyer group 2: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”’

Buyer group 3: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ

โ—โ— companies
Description: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
Key Products: โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ
๐Ÿ”’ View all companies in this group
Request Free Trial Now โ†’
๐Ÿ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial โ†’

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cyclo Therapeutics

2.2 - Growth funds investing in similar companies to Cyclo Therapeutics

๐Ÿ”’ View all growth equity funds with complete profiles
Start Free Trial โ†’

4 - Top valuation comps for Cyclo Therapeutics

4.2 - Public trading comparable groups for Cyclo Therapeutics

๐Ÿ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial โ†’

4.3 - M&A Transactions similar to Cyclo Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
๐Ÿ”’ View all M&A transactions with complete deal terms
Request Free Trial Now โ†’

Frequently Asked Questions

About Cyclo Therapeutics

What does Cyclo Therapeutics do?

Cyclo Therapeutics is a provider of cyclodextrin-based therapeutics, including Trappsolยฎ Cycloโ„ข, a proprietary hydroxypropyl beta cyclodextrin formulation in clinical trials for Niemann-Pick Disease Type C1 and in a Phase 2b trial for early Alzheimerโ€™s disease, leveraging data from an Expanded Access program.

Who are Cyclo Therapeutics's competitors?

Cyclo Therapeutics's competitors and similar companies include Questcor Pharmaceuticals, Exzell Pharma, LEAF Pharmaceuticals, CTI Science, and Ascendis Pharma.

Where is Cyclo Therapeutics headquartered?

Cyclo Therapeutics is headquartered in United States.

How many employees does Cyclo Therapeutics have?

Cyclo Therapeutics has 1,000 employees ๐Ÿ”’.

When was Cyclo Therapeutics founded?

Cyclo Therapeutics was founded in 2010 ๐Ÿ”’.

What sector and industry vertical is Cyclo Therapeutics in?

Cyclo Therapeutics is in the Enterprise Software ๐Ÿ”’ sector and industry

M&A Buyers & Acquirers for Cyclo Therapeutics

Who are the top strategic acquirers in Cyclo Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Cyclo Therapeutics's sector include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Which M&A buyer groups are most relevant for Cyclo Therapeutics?

Top strategic M&A buyers groups and sectors for Cyclo Therapeutics include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ , โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Financial Investors investing in Cyclo Therapeutics's sector and industry vertical

Which are the top PE firms investing in Cyclo Therapeutics's sector and industry vertical?

Top PE firms investing in Cyclo Therapeutics's sector and industry vertical include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Who are the top buyout funds acquiring in Cyclo Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cyclo Therapeutics's sector and industry vertical include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Who are the top growth equity funds investing in companies in Cyclo Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cyclo Therapeutics include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Valuation benchmarks of companies in Cyclo Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cyclo Therapeutics?

The key public trading comparables and valuation benchmarks for Cyclo Therapeutics include โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ, and โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ ๐Ÿ”’.

Which are the key trading comparable groups for Cyclo Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cyclo Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cyclo Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cyclo Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cyclo Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Cyclo Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cyclo Therapeutics